Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression
- 27 September 2010
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 63 (10) , 894-899
Abstract
Background The assessment of malignant potential of oral submucous fibrosis grades vis-à-vis their progression towards malignancy is associated with expression of possible multiple molecular markers. Aims To analyse p63, E-cadherin and CD105 expression in this premalignant pathosis with a view to unravel and understand the expression of these molecules as markers. Methods The oral mucosal biopsies (normal, oral submucous fibrosis with and without dysplasia) were studied with routine H&E, and by immunohistochemistry for p63, E-cadherin and CD105 expression. p63 was assessed as percentage of positive nuclei. E-cadherin expression was estimated through (i) distance between basement membrane and E-cadherin expression initiation point, (ii) ratio between epithelial thickness and epithelial thickness displaying E-cadherin, and (iii) E-cadherin intensity variation along the expression path. CD105 expression was assessed qualitatively. Results The p63+ cells were highest in severely dysplastic tissues followed by other dysplastic grades, normal oral mucosa and non-dysplastic conditions. However, the p63+ cells displayed the feature of progressive maturation only in normal mucosa. There was a loss of membranous E-cadherin in basal layers of all diseased conditions; it was highest in severe dysplasia. There was significant variation (pConclusions The malignant potential of this pre-cancerous condition is likely to be correlated with an increase in p63 and CD105 expression and a concomitant loss of membranous E-cadherin. This may lead to marker identification through greater validation.Keywords
This publication has 34 references indexed in Scilit:
- p63 Immunoexpression in lip carcinogenesisJournal of Molecular Histology, 2009
- Morphological evidence of basal keratinocyte migration during the re-epithelialization processHistochemistry and Cell Biology, 2008
- C-terminal peptide of IGFBP-3, KGRKR, prolongs the proliferative potential of basal keratinocytesJournal of Dermatological Science, 2008
- Expression pattern of p63 in oral epithelial lesions and submucous fibrosis associated with betel-quid chewing in Sri LankaMedical Molecular Morphology, 2007
- Update on Oral Epithelial Dysplasia and Progression to CancerHead and Neck Pathology, 2007
- Oral submucous fibrosis: Review on aetiology and pathogenesisOral Oncology, 2006
- Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinomaOral Oncology, 2006
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- E-cadherin expression in normal, hyperplastic and malignant oral epitheliumOral Oncology, 1993
- Oral submucous fibrosisOral Surgery, Oral Medicine, Oral Pathology, 1966